Clinical and Immunological Responses in Subjects Sensitive to Solvents

Archives of Environmental Health

Volumn 54, Issue 1, 1999, Pages 6-14

  Little, Colin H ^a   Georgiou, George M ^b   Shelton, Michael J ^b   Simpson, Faye ^c   Cone, Robert E ^d  

^a Specialist Allergist   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c Neuropsychologist Mt Waverley ^*  (Australia)

^d UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBENZOIC ACID; HUMAN SERUM ALBUMIN; IMMUNOGLOBULIN G; T LYMPHOCYTE ANTIGEN; TOLUENE;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNE RESPONSE; LONG TERM MEMORY; MALE; MULTIPLE CHEMICAL SENSITIVITY; NEUROPSYCHOLOGY; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE;

EID: 0032936552     PISSN: 00039896     EISSN: None     Source Type: Journal    
DOI: 10.1080/00039899909602230     Document Type: Article

References (42)

1. Zeim G, Davidoff L. Illness from chemical –odors—: is the health significance understood? Arch Environ Health 1992, 47:88-91
2. Davioff A, Fogarty L. Psychogenic origins of Multiple Chemical Sensitivity Syndrome: a critical review of the research literature, Arch Environ Health 1993, 49:316-25
3. Richter R. Multiple Chemical Sensitivity: respect the observations. Suspect the interpretations? Arch Environ Health 1993, 48: 366-67
4. Kilburn K. How should we think about chemically reactive patients? Arch Environ Health 1993, 48:4-5
5. Ashford N, Miller C. –Chemical Sensitivity—: A Report for the New Jersey State Department of Health. December 1989
6. Simon G, Daniel I W, Stockbridge H, et al. Immunological, psychological and neuropsychological factors in Multiple Chemical Sensitivity. Ann Intern Med 1993, 119:97-103
7. Stauden Mayer H, Seiner J, Buhr M. Double-blind provocation chamber challenges in 20 patients presenting with –Multiple Chemical Sensitivity.— Reg Toxicol Pharmacol 1993, 18:44-53
8. Bell I, Miller C, Schwartz G. An olfactory-limbic model of Multiple Chemical Sensitivity Syndrome: possible relationship to kindling and affective spectrum disorders. Biol Psychiatry 1992, 32:218-42
9. Aebischer I, Stadler BM. Th1-Th2 cells in allergic responses: at the limits of a concept. Adv Immunol 1996, 61:341-415
10. Cone RE. Soluble extracellular antigen-specific T-cell immunoproteins. J Leukocyte Biol 1996, 59:605-12
11. Urbanski M, Cone R. Appearance of T-lymphocyte-derived proteins specific for the immunizing antigen in serum during a humoral immune response. J Immunol 1992, 148:2840-44
12. Hadjicouti C, Wang Y, O'Rourke J, et al. Intracameral injection of antigen potentiates the production of antigen-specific T-cell proteins after induction of delayed-type sensitivity. Inv Ophthalmol Vis Sci 1995, 36:1470-76
13. Ferguson TA, Herndon JM. The immune response and the eye: the ACAID-inducing signal is dependent on the nature of the antigen. Invest Opthamol Vis Sci 1994, 35:3085-93
14. Ferguson TA, Iverson CM. Isolation and characterization of an antigen-specific suppressor-inducer molecule from serum of hyperimmune mice using monoclonal antibody. J Immunol 1986, 136:2896-2903
15. DiBrino M, Ravindran B, Cone RE. T-cell-derived proteins from normal human sera and their relationship to T-cell antigen-binding molecules. Clin Immunol Immunopathol 1991, 59:271-97
16. Urbanski M, Cone RE. T-cell-derived antigen-specific humoral immune response. II. Further characterization of the response and the antigen-binding T-cell immunoproteins. Cell Immunol 1994, 153:131-41
17. Wang Y, O'Rourke I, Cone RE. Serum TABM produced during anterior chamber-associated immune deviation (ACAID) passively transfers suppression of delayed-type hypersensitivity to primed mice. Inti Immunol 1997, 9:211-18
18. Cone RE, Wang Y, O'Rourke J, et al. Extracellular (soluble) antigen-specific T-cell proteins related to the T-cell receptor (sTcRr). Serological and primary amino acid sequence similarity to T-cell receptor alpha chains and association with cytokines. J Interferon Cytokine Res 1998, 18:55-67
19. Cone RE, Malley A. Soluble antigen-specific T-cell proteins: T-cell-based humoral immunity? Immunol Today 1996, 17:318-22
20. Hanninen H. Methods in behavioural toxicology. Current test Batteries and Need for Development Workshops on Behavioral Aspects of Neurotoxicity: Critical Issues. 1988 (Canberra unpublished proceedings)
21. Russell RW, Flattau PE, Pope AM (Eds). Behavioural Measures of Neural Toxicity. Report of a Symposium. National Academy Press, 1990. [QUERY: City/State of National Academy Press?]
22. Lesak MD. Neuropsychological Assessment (2nd ed). New York: Oxford University Press, 1993
23. Golden CJ. STROOP Colour Word Test Manual. Chicago, IL: Stoelting, 1978
24. Smith A. Symbol Digit Modality Test Manual. Los Angeles, CA: Western Psychological Service, 1982
25. Vojdani A, Choneum M, Brautbar N. Immune alterations associated with exposure to toxic chemicals. Toxicol Ind Health 1992, 8:239-53
26. Rosenstein R, Murray J, Cone R, et al. Isolation and partial characterization of an antigen-specific T-cell factor associated with suppression of delayed-type hypersensitivity. Proc Natl Acad Sci 1981, 78:5821-25
27. Cone R. Soluble T lymphocyte antigen-specific molecules. Proc Soc Exp Biol Med 1992, 200:296-302
28. Cone RE, Marchalonis O. Partial amino acid sequence of monoclonal extracellular antigen-specific T-cell proteins. Immunol Invest 1993, 22:541-52
29. Lof A, Wigaens Hjelm E, Colmsjo A, et al. Toxicokinetics of toluene and urinary excretion of hippuric acid after human exposure to 2H8-toluene. BrJ Ind Med 1993, 50:55-59
30. Pathiratne A, Puyear RL, Brammer JD. Activation of l4C-toluene to covalently binding metabolites by rat liver microsomes. Drug Metab Dispos 1986, 14:386-91
31. Bakke O, Scheline R. Hydroxylation of aromatic hydrocarbons in the rate. Toxicol Appl Pharmacol 1970, 16:691-700
32. Jerina D, Daly J, Witkop B, et al. Role of the arena oxide-oxeoin systems in the metabolism of aromatic substrates. Arch Biochem Biophys 1968, 128:176-83
33. Angerer J. Occupational chronic exposure to organic solvents. Metabolism of toluene in man. Int Arch Occup Environ Health 1979, 43:63-67
34. Cone R, Gerardi D, Davidoff J, et al. Quantitation of T-cell antigen-binding molecules (TABM) in the sera of nonimmunised, immunised, and desensitised mice. J Immunol 1987, 138: 234-39
35. Cone RE, Wang Y, O'Rourke J, et al. On the role of extracellular antigen-specific T-cell proteins in immune deviation by intracameral soluble protein antigens. In: Nussenblatt RB, Whit-cup SM, Caspi KR, Grey I (Eds). Advances in Occular Immunology. Amsterdam, the Netherlands: Elsevier Press, 1994, pp 169-74
36. Meade R, Askenase P, Geba G, et al. Transforming growth factor ?1 inhibits murine immediate and delayed hypersensitivity. J Immunol 1992, 149:521-28
37. Powrie F, Menon S, Coffman R. Interleukin 4 and interleukin 10 synergise to inhibit cell-mediated immunity in vivo. Eur J Immunol 1993, 23:3043-4019
38. Li L, Elliot J, Mosman T. 1L-10 inhibits cytokine production, vascular leakage and swelling duringT helper cell-induced delayed-type hypersensitivity. Immunol 1994, 153:3967-78
39. Bretscher P. Significance and mechanisms of cell regulation of the immune response. Fed Proc 1981, 40:1473-78
40. Bretscher P. Decision criteria and coherence in the regulation of the immune response. In: Perelson AG (Ed). Theoretical Immunology. Addison, IL: Wesley Printing, 1988, pp 295-310
41. Bretscher P. An hypothesis to explain why cell-mediated immunity alone can contain infections by certain intracellular parasites and how immune class regulation of the response against such parasites can be subverted. Immunol Cell Biol 1992, 70:343-51
42. Friedman A, Weiner H. Induction of anergy or active suppression following oral tolerance is determined by antigen dose. Proc Natl Acad Sci 1994, 91:6688-92